Surface engineered nanohybrids in plasmonic photothermal therapy for cancer: Regulatory and translational challenges
Nanotheranostics · 2024 · 8 (2) · 202-218
DOI: 10.7150/ntno.92639 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanotheranostics, 2024. Verfasst von Monalisha Debnath und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India. Hauptthemen laut MEDLINE: Photothermal Therapy, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India.
Zitieren
APA
Debnath, M., Debnath, S. K., Talpade, M. V., Bhatt, S., Gupta, P. P., & Srivastava, R. (2024). Surface engineered nanohybrids in plasmonic photothermal therapy for cancer: Regulatory and translational challenges. Nanotheranostics, 8(2), 202-218. https://doi.org/10.7150/ntno.92639
Vancouver
Debnath M, Debnath SK, Talpade MV, Bhatt S, Gupta PP, Srivastava R. Surface engineered nanohybrids in plasmonic photothermal therapy for cancer: Regulatory and translational challenges. Nanotheranostics. 2024;8(2):202-218. doi:10.7150/ntno.92639
BibTeX
@article{Debnath2024,
author = {Debnath, Monalisha and Debnath, Sujit Kumar and Talpade, Mangal Vishnu and Bhatt, Shweta and Gupta, Prem Prakash and Srivastava, Rohit},
title = {Surface engineered nanohybrids in plasmonic photothermal therapy for cancer: Regulatory and translational challenges},
journal = {Nanotheranostics},
year = {2024},
volume = {8},
number = {2},
pages = {202--218},
doi = {10.7150/ntno.92639}
}
EUVIMED